AusPAR: Flucelvax Quad

Australian Public Assessment Report

AusPAR

AusPAR: Flucelvax Quad [PDF, 1.52 MB]

AusPAR: Flucelvax Quad [Word, 3.58 MB]

AusPAR Attachment 1: Product Information for Flucelvax Quad [PDF, 259.1 KB]

AusPAR Attachment 1: Product Information for Flucelvax Quad [Word, 419.5 KB]

Device/Product Name

Flucelvax Quad

Active ingredients

Quadrivalent influenza vaccine (surface antigen, inactivated)

AusPAR Date

18 November 2022

Published

5 December 2022

Submission Number

PM-2020-05368-1-2

Submission Type

Extension of indications

Decision

Approved